Bae Si Hyun, Jang Jeong Won, Kim Min Soo, Oh Hyun Jong, Choi Jong Young, Han Nam Ik, Yoon Seung Kew, Han Joon Yeol, Oh Eun Jee, Kim Dong Gu
Department of Internal Medicine, Kangnam St. Marys Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
Korean J Gastroenterol. 2005 May;45(5):369-73.
Liver transplantation is the only curative therapy for patients with end-stage liver disease. The high success rate and the increasing demand for the transplantation sometimes calls for ABO-compatible but nonidentical blood group orthotopic liver transplantation (OLT), which affords the opportunity to the production of antibody to red blood cells. Hemolytic anemia usually occurs 1 to 2 weeks after transplantation. Although mild in most patients, it can be life-threatening. Until now, a few cases showing hemolytic anemia due to donor ABO antibody formation after ABO-nonidentical OLT have been reported. In the reported cases of hemolytic anemia, most ABO-nonidentical OLT cases were O-to-A, but few reports are available on this subject with O-to-B ABO-nonidentical OLT. Herein, we report the experience with hemolysis after ABO-nonidentical OLT in a group O donor into a group B recipient and the successful treatment with transfusion of washed group O red blood cells and 60 mg dose of prednisolone for 3 days.